Genentech, Inc. et al v. Sanofi-Aventis Deutschland GMBH et al

Filing 519

STIPULATION AND ORDER CONTINUING ADR DEADLINE. Signed by Judge Susan Illston on 11/01/10. (sis, COURT STAFF) (Filed on 11/1/2010)

Genentech, Inc. et al v. Sanofi-Aventis Deutschland GMBH et al

Doc. 519

1 Counsel Listed on Following Page 2 3 4 5 6 7 8 9 10 11 12 13 SANOFI-AVENTIS DEUTSCHLAND GMBH, 14 15 16 vs. Plaintiff, STIPULATION AND [PROPOSED] ORDER CONTINUING ADR DEADLINE [Civil L.R. 6-1, 6-2] Honorable Susan Illston United States District Judge CASE NOS. C 08-4909 SI (BZ) C 09-4919 SI UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION

17 GENENTECH, INC. and BIOGEN IDEC INC., 18 19 20 21 22 23 24 25 26 27 28
STIPULATION AND [PROPOSED] ORDER CONTINUING ADR DEADLINE

Defendants.

Case Nos. C 08-4909 SI (BZ) C 09-4919 SI Dockets.Justia.com

1 QUINN EMANUEL URQUHART & 2 SULLIVAN, LLP Charles K. Verhoeven (Bar No. 170151) 3 [e-mail] 50 California Street, 22nd Floor 4 San Francisco, California 94111 Telephone: [phone] Facsimile: [phone] Victoria F. Maroulis (Bar No. 202603) [e-mail] 7 Gabriel S. Gross (Bar No. 254672) [e-mail] 8 555 Twin Dolphin Drive, 5th Floor Redwood Shores, California 94065-2139 9 Telephone: [phone] Facsimile: [phone] 10 Attorneys for Defendant Genentech, Inc. 11 TOWNSEND, TOWNSEND & CREW LLP 12 James G. Gilliland (Bar No. 107988) [e-mail] 13 David J. Tsai (Bar No. 244479) [e-mail] 14 Two Embarcadero Center, Eighth Floor 15 San Francisco, CA 94111 Telephone: [phone] Facsimile: [phone] 17 Anne M. Rogaski (Bar No. 184754) [e-mail] 18 379 Lytton Avenue 19 Palo Alto, CA 94301 Telephone: [phone] Facsimile: [phone] 21 22 23 24 25 26 27 28 -1STIPULATION AND [PROPOSED] ORDER CONTINUING ADR DEADLINE Case Nos. C 08-4909 SI (BZ) C 09-4919 SI

6

FOLEY HOAG LLP Donald R. Ware (pro hac vice) [e-mail] Claire Laporte (pro hac vice) [e-mail] Jeremy A. Younkin [e-mail] Seaport World Trade Center West 155 Seaport Boulevard Boston, MA 02210-2600 Telephone: [phone] Facsimile: [phone] Attorneys for Defendant Biogen Idec Inc. HARVEY SISKIND LLP D. Peter Harvey (Bar No. 55712) [e-mail] Naomi Jane Gray [e-mail] Raffi V. Zerounian (Bar No. 236388) [e-mail] Four Embarcadero Center, 39th Floor San Francisco, California 94111 Telephone: [phone] Facsimile: [phone] FITZPATRICK, CELLA, HARPER & SCINTO William E. Solander (admitted pro hac vice) [e-mail] Dominick A. Conde (admitted pro hac vice) [e-mail] Peter D. Shapiro (admitted pro hac vice) [e-mail] Joshua A. Davis (admitted pro hac vice) [e-mail] 1290 Avenue of the Americas New York, New York 10104 Telephone: [phone] Facsimile: 212-218-2200 Attorneys for Plaintiff Sanofi-Aventis Deutschland GmbH

1

Pursuant to Civil Local Rules 6-1 and 6-2, Plaintiff Sanofi-Aventis Deutschland GmbH

2 ("Sanofi") and Defendants Genentech, Inc. ("Genentech") and Biogen Idec Inc. ("Biogen") 3 respectfully request that the Court enter the following stipulation regarding the deadline for 4 conducting ADR. The parties now AGREE AND STIPULATE to extend the deadline for the 5 parties to conduct an ADR from October 31, 2010 to January 31, 2011. 6 7 1. Reason for the Request

In its Order Selecting ADR Process (D.N. 74), the Court directed the parties to conduct a

8 private ADR session 60 days after the entry of the Claim Construction Order. The Court issued its 9 Claim Construction Order on June 23, 2010. On August 4, the parties requested additional time to 10 select an appropriate mediator for this dispute, extending the deadline to conduct ADR to October 11 31, 2010. The parties have agreed on a mediator, but due to the mediator's limited availability 12 through the end of 2010, the mediation will be scheduled to occur in January 2011. 13 14 2. Prior Time Modifications

The time for Sanofi to answer or otherwise respond to the Complaint was previously

15 extended. The briefing and hearing schedule for Motions to Dismiss for Lack of Jurisdiction brought 16 by Sanofi and its former co-defendants was temporarily vacated. The briefing and hearing schedule 17 for Genentech's Motion To Disqualify McDonnell Boehnen Hulbert and Berghoff LLP was 18 extended by four weeks. The briefing and hearing schedule for Sanofi's Motion for Leave to 19 Amend Its Pleadings and Infringement Contentions was previously extended by five weeks and then 20 extended again by seven weeks. The Markman hearing and tutorial were previously continued by 21 45 days. The date for Plaintiff's oppositions to Defendants' motions for summary judgment was 22 extended by approximately three weeks. The date for Defendants' replies to Plaintiff's summary 23 judgment oppositions was extended by one week. A previous extension of time to conduct ADR is 24 described above. 25 26 27 28 -2STIPULATION AND [PROPOSED] ORDER CONTINUING ADR DEADLINE Case Nos. C 08-4909 SI (BZ) C 09-4919 SI

3.

Effect of Requested Modification

The requested modification will have no effect on the rest of the schedule in this action. So Stipulated.

1 DATED: October 27, 2010 2 3 4 5 6 7 8 DATED: October 27, 2010 9 10 11 12 13 14 DATED: October 27, 2010 15 16 17 18 19 20
UNIT ED

HARVEY SISKIND LLP FITZPATRICK, CELLA, HARPER & SCINTO

By /s/ William E. Solander Attorneys for Plaintiff Sanofi-Aventis Deutschland GmbH

QUINN EMANUEL URQUHART & SULLIVAN, LLP

By /s/ Victoria F. Maroulis Attorneys for Defendant Genentech, Inc.

TOWNSEND TOWNSEND AND CREW LLP FOLEY HOAG LLP

By /s/ Claire Laporte Attorneys for Defendant Biogen Idec Inc.

21 22 23 24 25 26 27 28

PURSUANT TO STIPULATION, IT IS SO ORDERED.

S

ISTRIC ES D TC AT T

DATED: 11/01/10

___________________________________________ ER C N The Honorable Susan Illston F D IS T IC T O R United States District Court Judge
H
A

-3STIPULATION AND [PROPOSED] ORDER CONTINUING ADR DEADLINE Case Nos. C 08-4909 SI (BZ) C 09-4919 SI

LI

FO

Judge S

usan Ill

ston

R NIA

RT U O

NO

RT